The Missing Piece in Pediatric Reflux.
Four million children need GERD evaluation annually, yet many families refuse invasive pH monitoring procedures, leaving physicians to treat based on symptoms alone. Veritas Dx has developed the world's first non-invasive pediatric GERD diagnostic—a simple oral swab that delivers definitive results in a 5-minute office visit, replacing $2,000 invasive procedures with a gentle, accurate solution that physicians and parents embrace. Founded by a practicing dentist who sees oral damage from reflux firsthand, Veritas Dx is partnering with ISO-certified manufacturer to bring this life-changing diagnostic to market, creating an entirely new standard of care for millions of children worldwide.
About Us
Veritas Dx emerged from a simple observation: the best medical innovations often come from unexpected perspectives. Our founder, Dr. Stewart, wasn't looking to revolutionize pediatric diagnostics when she first noticed the oral signs of gastric reflux in her dental patients. But her unique vantage point—seeing both the consequences of reflux and the potential for oral biomarker detection—sparked the insight that would become our core technology.
Today, we're a medical device company backed by experienced partners and focused on bringing breakthrough diagnostics to market. Our team combines clinical experience with business expertise, supported by a manufacturer with proven capabilities and a regulatory track record.
We're building more than a single product—we're establishing a new approach to pediatric diagnostics that puts patient experience at the center of clinical decision-making.
Contact Us
Join Our Mission Whether you're a healthcare provider, investor, or parent who believes children deserve better, we invite you to be part of this transformation. Together, we can make traumatic pediatric procedures a thing of the past.